About Crelux
Crelux is a company based in Planegg (Germany) founded in 2005 was acquired by WuXi AppTec in April 2016.. Crelux offers products and services including CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD. Crelux operates in a competitive market with competitors including Proteros, Nabla, Biomatter, Syrrx and Fina Biosolutions, among others.
- Headquarter Planegg, Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Crelux Solutions Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$862.78 K (USD), Grant
Apr 01, 2015
-
Investors
WuXi AppTec
& 1 more
-
Employee Count
Employee Count
-
Acquired by
WuXi AppTec
(Apr 15, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Crelux
Crelux offers a comprehensive portfolio of products and services, including CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for supplying high-quality proteins to expedite drug discovery projects.
Off-the-shelf service for early-stage drug discovery and fragment screening.
Gene-to-structure service supporting drug discovery through advanced imaging.
Platform for target validation and hit confirmation in drug development.
Technology for hit finding and lead optimization in pharmaceutical research.
Unlock access to complete
Unlock access to complete
Funding Insights of Crelux
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $862,778
-
First Round
First Round
(01 Apr 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Grant - Crelux | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Crelux
Crelux has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include WuXi AppTec and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Provider of CRO and CDMO services
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Crelux
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Crelux
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crelux Comparisons
Competitors of Crelux
Crelux operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proteros, Nabla, Biomatter, Syrrx and Fina Biosolutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery services are provided to researchers in protein biochemistry.
|
|
| domain | founded_year | HQ Location |
Synthetic biology platform for functional protein identification is provided.
|
|
| domain | founded_year | HQ Location |
Provider of synthetic biology and AI-based technology for generative protein design
|
|
| domain | founded_year | HQ Location |
Provider of drug targets research and clinical trial services
|
|
| domain | founded_year | HQ Location |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| domain | founded_year | HQ Location |
Protein expression, purification, and structural biology services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Crelux
When was Crelux founded?
Crelux was founded in 2005 and raised its 1st funding round 10 years after it was founded.
Where is Crelux located?
Crelux is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
What does Crelux do?
Crelux was founded in 2005 in Planegg, Germany, as a provider of solutions for early-stage drug development within the biotechnology sector. Expertise is focused on protein production, biophysical screening, and X-ray crystallography. Services encompass hit-finding, validation, optimization technologies, and protein biochemistry, marketed under brands such as PRIME PROTEINS, XPRESS, XPERTXPEDITE, and INTRACT. Operations support research partnerships globally.
What products or services does Crelux offer?
Crelux offers CRELUX Protein, X-ray Crystallography, Cryo-EM, Biophysics and Biochemistry, and Fragment Screening and FBDD.
Who are Crelux's investors?
Crelux has 2 investors. Key investors include WuXi AppTec, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.